Hematology/Oncology — Medicare Part B billing by state
286 physician groups whose primary specialty is Hematology/Oncology billed $2.4B to Medicare fee-for-service in 2023.
Calendar year 2023 · Medicare fee-for-service Part B
You're viewing calendar year 2023. State market links open the latest data year.
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Florida | $402.3M | $400.6M | 37 | $10.8M | 35.2M | 1.9M | 950K |
| Texas | $332.3M | $327.1M | 30 | $10.9M | 25.5M | 1.3M | 849K |
| New York | $165.3M | $175.4M | 31 | $5.7M | 11.5M | 1.2M | 370K |
| California | $146.6M | $151.7M | 44 | $3.4M | 11.3M | 430K | 256K |
| Tennessee | $119.5M | $115.9M | 19 | $6.1M | 8.8M | 452K | 461K |
| Arkansas | $111.1M | $107.7M | 5 | $21.5M | 8.4M | 424K | 1.7M |
| Virginia | $105.5M | $105.5M | 21 | $5.0M | 6.9M | 310K | 328K |
| Illinois | $99.4M | $98.9M | 23 | $4.3M | 9.6M | 324K | 418K |
| Maryland | $80.2M | $81.4M | 17 | $4.8M | 7.2M | 199K | 426K |
| Alabama | $66.3M | $64.3M | 13 | $4.9M | 3.5M | 217K | 268K |
| Georgia | $64.9M | $63.5M | 24 | $2.6M | 4.2M | 255K | 174K |
| Kansas | $60.0M | $59.2M | 5 | $11.8M | 4.0M | 149K | 793K |
| Nevada | $57.7M | $57.0M | 7 | $8.1M | 4.6M | 198K | 659K |
| Arizona | $57.6M | $56.8M | 10 | $5.7M | 4.5M | 134K | 447K |
| Pennsylvania | $49.7M | $49.7M | 26 | $1.9M | 3.9M | 165K | 148K |
| Colorado | $49.4M | $49.5M | 7 | $7.1M | 2.8M | 142K | 406K |
| Ohio | $45.5M | $44.2M | 21 | $2.1M | 3.1M | 153K | 149K |
| North Carolina | $44.7M | $43.7M | 23 | $1.9M | 2.6M | 175K | 112K |
| South Carolina | $42.5M | $41.3M | 9 | $4.6M | 3.2M | 116K | 353K |
| New Jersey | $37.7M | $39.2M | 20 | $2.0M | 3.5M | 128K | 175K |
| Mississippi | $34.3M | $32.7M | 6 | $5.5M | 2.3M | 75,960 | 385K |
| Oregon | $24.1M | $23.9M | 11 | $2.2M | 2.2M | 82,561 | 196K |
| Indiana | $23.8M | $23.3M | 10 | $2.3M | 1.9M | 83,146 | 190K |
| Washington | $21.0M | $21.0M | 13 | $1.6M | 1.8M | 74,666 | 136K |
| Delaware | $17.5M | $17.5M | 2 | $8.7M | 749K | 18,018 | 375K |
| Nebraska | $16.6M | $16.4M | 6 | $2.7M | 1.2M | 38,216 | 194K |
| Louisiana | $12.7M | $12.2M | 8 | $1.5M | 729K | 36,808 | 91,137 |
| Maine | $11.5M | $11.4M | 3 | $3.8M | 809K | 27,524 | 270K |
| Michigan | $11.0M | $10.8M | 12 | $904K | 1.1M | 53,258 | 88,696 |
| Alaska | $9.3M | $9.5M | 3 | $3.2M | 408K | 10,947 | 136K |
| Missouri | $8.9M | $8.8M | 15 | $589K | 283K | 53,403 | 18,874 |
| New Mexico | $6.3M | $6.2M | 5 | $1.2M | 414K | 48,428 | 82,825 |
| Massachusetts | $5.2M | $5.3M | 9 | $588K | 359K | 16,736 | 39,931 |
| Connecticut | $4.5M | $4.6M | 8 | $581K | 401K | 23,566 | 50,064 |
| Iowa | $4.1M | $4.1M | 2 | $2.0M | 264K | 8,146 | 132K |
| Kentucky | $3.8M | $3.6M | 7 | $519K | 70,885 | 24,850 | 10,126 |
| Wisconsin | $2.4M | $2.3M | 7 | $329K | 208K | 24,500 | 29,692 |
| Rhode Island | $2.0M | $2.0M | 1 | $2.0M | 30,388 | 18,256 | 30,388 |
| PR | $1.4M | $1.4M | 7 | $194K | 58,003 | 5,185 | 8,286 |
| Hawaii | $1.1M | $1.2M | 1 | $1.2M | 56,880 | 10,450 | 56,880 |
| South Dakota | $1.1M | $1.1M | 2 | $552K | 30,763 | 1,659 | 15,382 |
| Oklahoma | $1.0M | $951K | 5 | $190K | 13,146 | 6,753 | 2,629 |
| New Hampshire | $1.0M | $1.0M | 3 | $341K | 115K | 3,128 | 38,212 |
| Minnesota | $647K | $642K | 8 | $80K | 50,034 | 2,602 | 6,254 |
| District of Columbia | $149K | $163K | 4 | $41K | 1,951 | 898 | 488 |
| VI | $100K | $99K | 1 | $99K | 1,440 | 577 | 1,440 |
| Idaho | $93K | $86K | 2 | $43K | 1,271 | 808 | 636 |
| North Dakota | $65K | $64K | 1 | $64K | 881 | 461 | 881 |
| Utah | $64K | $64K | 1 | $64K | 599 | 248 | 599 |
| Vermont | $64K | $61K | 1 | $61K | 590 | 298 | 590 |
| West Virginia | $21K | $22K | 2 | $11K | 273 | 201 | 136 |
| Montana | $18K | $18K | 1 | $18K | 216 | 99 | 216 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2023
5 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| J9271 · Injection, pembrolizumab, 1 mg | $647.3M | 15.1M | FLTXNYCATN |
| J0897 · Injection, denosumab, 1 mg | $163.2M | 8.9M | FLTXNYCATN |
| J9299 · Injection, nivolumab, 1 mg | $117.9M | 5.0M | FLTXNYCATN |
| J9144 · Injection, daratumumab, 10 mg and hyaluronidase-fihj | $110.8M | 2.9M | FLTXNYCATN |
| G6015 · Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | $51.2M | 184K | FLTXNYCATN |
| J0881 · Injection, darbepoetin alfa, 1 microgram (non-esrd use) top by services | $28.1M | 12.0M | FLTXNYCATN |
| J1439 · Injection, ferric carboxymaltose, 1 mg top by services | $22.0M | 25.2M | FLTXNYCATN |
| Q0138 · Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) top by services | $8.4M | 21.5M | FLTXNYCATN |
| J0185 · Injection, aprepitant, 1 mg top by services | $6.8M | 5.0M | FLTXNYCATN |
| J1756 · Injection, iron sucrose, 1 mg top by services | $1.3M | 8.1M | FLTXNYCATN |
| J1453 · Injection, fosaprepitant, 1 mg top by services | $751K | 6.2M | FLTXNYCATN |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | $666K | 5.9M | FLTXNYCATN |